BDPT — BioAdaptives Balance Sheet
0.000.00%
- $0.59m
- $0.80m
- $0.01m
Annual balance sheet for BioAdaptives, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.005 | 0.083 | 0.025 | 0.061 | 0.137 |
Net Total Receivables | — | — | — | — | 0.003 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.019 | 0.089 | 0.034 | 0.089 | 0.262 |
Net Intangible Assets | |||||
Total Assets | 0.019 | 0.149 | 0.037 | 0.104 | 0.262 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.4 | 1.24 | 1.49 | 1.75 | 1.73 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.4 | 1.24 | 1.49 | 1.75 | 1.73 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1.38 | -1.09 | -1.45 | -1.65 | -1.46 |
Total Liabilities & Shareholders' Equity | 0.019 | 0.149 | 0.037 | 0.104 | 0.262 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |